Francisco Molina-Garcia - Publications

Comprehensive Landscape of Diagnostic, Prognostic and Predictive Biomarkers in Colorectal Cancer: From Genomics to Multi-Omics Integration in Precision Medicine.

Journal: Journal of personalized medicine

Published: December 03, 2025

Molecular Docking Studies of Ortho-Substituted Phenols to Tyrosinase Helps Discern If a Molecule Can Be an Enzyme Substrate.

Journal: International journal of molecular sciences

Published: May 24, 2024

Diagnosis of lymph node metastases from papillary thyroid carcinoma by measuring thyroglobulin in the puncture needle. Calculation of optimal cut-off point in our series

Journal: Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia

Published: March 19, 2024

Considerations about the inhibition of monophenolase and diphenolase activities of tyrosinase. Characterization of the inhibitor concentration which generates 50 % of inhibition, type and inhibition constants. A review.

Journal: International journal of biological macromolecules

Published: December 31, 2023

Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes.

Journal: Breast cancer research and treatment

Published: October 30, 2023

Suramin, a drug for the treatment of trypanosomiasis, reduces the prothrombotic and metastatic phenotypes of colorectal cancer cells by inhibiting hepsin.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 30, 2023

Considerations on the action of polyphenoloxidase on 4-hydroxy-cinnamic acid. Molecular docking simulation.

Journal: Food chemistry

Published: March 24, 2023

Cardiac sarcoidosis as an infrequent cause of sudden death in asymptomatic young patients

Journal: Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia

Published: March 21, 2023

Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells.

Journal: Frontiers in molecular biosciences

Published: March 09, 2023

Implication of Hepsin from Primary Tumor in the Prognosis of Colorectal Cancer Patients.

Journal: Cancers

Published: May 31, 2022

The Relationship between the IC50 Values and the Apparent Inhibition Constant in the Study of Inhibitors of Tyrosinase Diphenolase Activity Helps Confirm the Mechanism of Inhibition.

Journal: Molecules (Basel, Switzerland)

Published: April 09, 2022

Considerations about the Continuous Assay Methods, Spectrophotometric and Spectrofluorometric, of the Monophenolase Activity of Tyrosinase.

Journal: Biomolecules

Published: August 12, 2021